Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Short term Debt (2020 - 2021)

Historic Short term Debt for Oncology Institute (TOI) over the last 2 years, with Q4 2021 value amounting to $183000.0.

  • Oncology Institute's Short term Debt fell 9659.09% to $183000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $183000.0, marking a year-over-year decrease of 9659.09%. This contributed to the annual value of $183000.0 for FY2021, which is 9659.09% down from last year.
  • Oncology Institute's Short term Debt amounted to $183000.0 in Q4 2021, which was down 9659.09% from $5.4 million recorded in Q4 2020.
  • In the past 5 years, Oncology Institute's Short term Debt registered a high of $5.4 million during Q4 2020, and its lowest value of $183000.0 during Q4 2021.